Home Biosimilar Antibodies Others Others antibody Ozanezumab (Anti-RTN4 / NOGO) For research use only.
Not for use in humans.

Ozanezumab (Anti-RTN4 / NOGO)

Synonyms: GSK1223249

Ozanezumab (Anti-RTN4 / NOGO) is a monoclonal antibody targeting Nogo-A (neurite outgrowth inhibitor A). It can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research. MW :150 KD.

Ozanezumab (Anti-RTN4 / NOGO)

Purity & Quality Control

≥99

Biological Activity

Description Ozanezumab (Anti-RTN4 / NOGO) is a monoclonal antibody targeting Nogo-A (neurite outgrowth inhibitor A). It can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research. MW :150 KD.

Product Details

CAS No. 1310680-64-8
Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ozanezumab (Anti-RTN4 / NOGO) | Ozanezumab (Anti-RTN4 / NOGO) supplier | purchase Ozanezumab (Anti-RTN4 / NOGO) | Ozanezumab (Anti-RTN4 / NOGO) cost | Ozanezumab (Anti-RTN4 / NOGO) manufacturer | order Ozanezumab (Anti-RTN4 / NOGO) | Ozanezumab (Anti-RTN4 / NOGO) distributor